Navigation Links
Westaim Announces Recommendation from RiskMetrics Group

TORONTO, March 15 /PRNewswire-FirstCall/ - The Westaim Corporation (Westaim or the Company) (TSX: "WED") announces that RiskMetrics Group (formerly Institutional Shareholder Services or "ISS") is recommending that its clients vote in favour of approving the financing resolution to be submitted to shareholders of Westaim at a special meeting of shareholders scheduled for March 25, 2010 (the Financing Resolution). The Financing Resolution relates to the issuance of up to 550 million common shares of Westaim, issuable on the conversion of an equal number of subscription receipts, recently sold by way of private placement. The subscription receipts were sold to finance the previously announced acquisition of JEVCO Insurance Company (JEVCO) from Kingsway Financial Services Inc.

RiskMetrics is widely recognized as one of the leading independent proxy voting and corporate governance advisory firms. Their analyses and recommendations are relied upon by many major institutional investment firms, mutual funds and fiduciaries throughout North America.

In its report issued on March 11, 2010 recommending that its clients vote to approve the Financing Resolution, RiskMetrics stated*:

        "WED has been searching for a new strategic investment opportunity.
        (Her Majesty the Queen in Right of the Province of Alberta) is
        expected to be a strong financial partner and the proposed
        transformational transaction provides WED with a new focus."

        "Management believes the acquisition will help create long term
        value...Market reaction has been positive and the stock is trading at
        its 52-week high."

"We are pleased that RiskMetrics supports our view that Westaim shareholders should vote FOR the Financing Resolution," said Cameron MacDonald, Westaim's President and Chief Executive Officer. "We urge shareholders not to delay voting their proxy, in order to ensure it is received in time to be counted at the Special Meeting."

A Management Information Circular, dated February 26, 2010 has been mailed to shareholders and filed on SEDAR ( and Westaim's web page ( The Circular contains, among other items, details regarding the Financing Resolution, the sale of the subscription receipts, the terms of the acquisition, the business of JEVCO and certain historical and pro forma financial information relating to JEVCO and Westaim.

About the Special Meeting

The Special Meeting (the "Meeting") of shareholders of The Westaim Corporation will be held at St. Andrew's Club and Conference Centre, 150 King Street West, 27th Floor, Toronto, Ontario, Canada on March 25, 2010 at 10:00 a.m. (Toronto time).

Shareholders who require assistance in voting their proxy may direct their inquiry to Westaim's proxy solicitation agent, Kingsdale Shareholder Services, 1-888-518-6813 or

About Westaim

Westaim invests, directly and indirectly, through acquisitions, joint ventures and other arrangements, with the objective of providing its shareholders with capital appreciation and real wealth preservation. Westaim's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

Certain portions of this press release as well as other public statements by Westaim, contain forward-looking statements. Such forward-looking statements include but are not limited to statements concerning the transaction described herein; investment strategies and expected rates of return; and strategic alternatives to maximize value for shareholder. These statements are based on current expectations that are subject to risks, uncertainties and assumptions and Westaim can give no assurance that these expectations are correct. Westaim's actual results could differ materially from those anticipated by forward-looking statements for various reasons generally beyond our control, including but not limited to: (i) failure to complete the transaction referred to herein; (ii) changes in market conditions or deterioration in underlying investments; (iii) general economic, market, financing, regulatory and industry developments and conditions; and (iv) other risk factors set forth in Westaim's Annual Report or Annual Information Form. Westaim disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise except as required by law. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.

*Permission to use quotations from the RiskMetrics report was neither sought nor obtained.

SOURCE Westaim Corporation

Back to top
SOURCE Westaim Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Westaim commences mailing of management information circular and announces new director
2. Westaim announces 2009 third quarter results
3. Westaim announces 2009 second quarter results
4. Westaim announces 2009 first quarter results
5. Westaim enters into Management Services Agreement
6. Westaim announces 2008 year-end results
7. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
8. Westaim announces 2008 third quarter results
9. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Third Quarter Results
10. Westaim terminates reorganization agreement and cancels shareholders meeting
11. Westaim to deregister its common stock in the United States
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... 26, 2016 , ... PawPaws brand pet supplements owned by Whole ... enhance the health of felines. The formula is all-natural and is made from Chinese ... PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract and ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... and Markets has announced the addition of the ... their offering. ... products and provides an updated review, including its applications ... covering the total market, which includes three main industries: ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology: